skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: ProQuest One Psychology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Material Type:
Article
Add to My Research

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

The New England journal of medicine, 2016-09, Vol.375 (11), p.1019-1032 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1603800 ;PMID: 27626517

Full text available

2
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Material Type:
Article
Add to My Research

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

The New England journal of medicine, 2015-05, Vol.372 (22), p.2087-2096 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1501184 ;PMID: 25916341

Full text available

3
Structure-based programming of lymph-node targeting in molecular vaccines
Material Type:
Article
Add to My Research

Structure-based programming of lymph-node targeting in molecular vaccines

Nature (London), 2014-03, Vol.507 (7493), p.519-522 [Peer Reviewed Journal]

COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Mar 27, 2014 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature12978 ;PMID: 24531764 ;CODEN: NATUAS

Full text available

4
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2021-02, Vol.397 (10275), p.682-694 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00241-5 ;PMID: 33524311

Full text available

5
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Material Type:
Article
Add to My Research

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Nature (London), 2022-01, Vol.601 (7894), p.617-622 [Peer Reviewed Journal]

2022. The Author(s). ;Copyright Nature Publishing Group Jan 27, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04232-5 ;PMID: 34814158

Full text available

6
Vaccine protection against Zika virus from Brazil
Material Type:
Article
Add to My Research

Vaccine protection against Zika virus from Brazil

Nature (London), 2016-08, Vol.536 (7617), p.474-478 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Aug 25, 2016 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature18952 ;PMID: 27355570 ;CODEN: NATUAS

Full text available

7
Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines
Material Type:
Article
Add to My Research

Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines

The New England journal of medicine, 2023-03, Vol.388 (12), p.1142-1145 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2216233 ;PMID: 36856580

Full text available

8
An invariant Trypanosoma vivax vaccine antigen induces protective immunity
Material Type:
Article
Add to My Research

An invariant Trypanosoma vivax vaccine antigen induces protective immunity

Nature (London), 2021-07, Vol.595 (7865), p.96-100 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jul 1, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03597-x ;PMID: 34040257

Full text available

9
How protein-based COVID vaccines could change the pandemic
Material Type:
Article
Add to My Research

How protein-based COVID vaccines could change the pandemic

Nature (London), 2021-11, Vol.599 (7885), p.359-360 [Peer Reviewed Journal]

Copyright Nature Publishing Group Nov 18, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03025-0 ;PMID: 34750543

Full text available

10
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Material Type:
Article
Add to My Research

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Nature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199

Full text available

11
Immunotherapy offers a promising bet against brain cancer
Material Type:
Article
Add to My Research

Immunotherapy offers a promising bet against brain cancer

Nature (London), 2018-09, Vol.561 (7724), p.S42-S44 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-018-06705-6 ;PMID: 30258155

Full text available

12
The race for coronavirus vaccines: a graphical guide
Material Type:
Article
Add to My Research

The race for coronavirus vaccines: a graphical guide

Nature (London), 2020-04, Vol.580 (7805), p.576-577 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-020-01221-y ;PMID: 32346146

Full text available

13
Building a better lymphoma vaccine
Material Type:
Article
Add to My Research

Building a better lymphoma vaccine

Nature (London), 2018-11, Vol.563 (7731), p.S52-S54 [Peer Reviewed Journal]

ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-018-07366-1 ;PMID: 30429570

Full text available

14
Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial
Material Type:
Article
Add to My Research

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial

The Lancet (British edition), 2003-12, Vol.362 (9400), p.1959-1966 [Peer Reviewed Journal]

2003 Elsevier Ltd ;2004 INIST-CNRS ;Copyright Lancet Ltd. Dec 13, 2003 ;Copyright Elsevier Limited Dec 13, 2003 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(03)15014-3 ;PMID: 14683655 ;CODEN: LANCAO

Full text available

15
Save the children
Material Type:
Article
Add to My Research

Save the children

Nature, 2004-08, Vol.430 (7002), p.940-941 [Peer Reviewed Journal]

COPYRIGHT 2004 Nature Publishing Group ;Copyright Macmillan Journals Ltd. Aug 19, 2004 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/430940a ;PMID: 15318239 ;CODEN: NATUAS

Full text available

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait